High hsCRP may up risk of macular edema in T1DM

High hsCRP may up risk of macular edema in T1DM
For patients with type 1 diabetes mellitus, elevated levels of high-sensitivity C-reactive protein are associated with an increased risk of clinically significant macular edema and with the development of retinal hard exudates, according to a study published online Feb. 7 in JAMA Ophthalmology.

(HealthDay)—For patients with type 1 diabetes mellitus, elevated levels of high-sensitivity C-reactive protein (hsCRP) are associated with an increased risk of clinically significant macular edema (CSME) and with the development of retinal hard exudates, according to a study published online Feb. 7 in JAMA Ophthalmology.

In a large multicenter randomized trial (Diabetes Control and Complications Trial [DCCT]), Rajeev H. Muni, M.D., from St. Michael's Hospital and the Hospital for Sick Children in Toronto, and colleagues examined whether baseline hsCRP and intercellular adhesion molecule 1 (ICAM-1) levels predict the development and progression of , CSME, and retinal hard exudates. The study population included 1,441 subjects with .

After adjustment for randomized treatment assignment and additional variables, the researchers identified an association between hsCRP and the risk of CSME (relative risk, 1.83 for highest versus lowest quintile; 95 percent confidence interval [CI], 0.94 to 3.55) and for the development of retinal hard exudates (relative risk, 1.78 for highest versus lowest quintile; 95 percent CI, 0.98 to 3.25). For ICAM-1, the relative risk of developing retinal hard exudates was 1.50 for the highest versus lowest quintile (95 percent CI, 0.84 to 2.68).

"After adjusting for known risk factors, increasing quintiles of baseline level may be associated with higher risk of incident CSME and macular hard exudate in the DCCT cohort," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Microaneurysm turnover IDs macular edema development

date Jan 08, 2013

(HealthDay)—Microaneurysm (MA) turnover independently predicts the development of clinically significant macular edema (CSME) in patients with non-proliferative diabetic retinopathy (NPDR), according to ...

Findings support link between hsCRP, macular degeneration

date Feb 08, 2013

(HealthDay)—Pooled results from five cohorts confirm that high levels of high-sensitivity C-reactive protein (hsCRP) correlate with increased future risk of age-related macular degeneration (AMD), according ...

Clopidogrel after MI less effective in diabetes patients

date Sep 05, 2012

(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue ...

Low HDL cholesterol ups risk of diabetic nephropathy

date Aug 22, 2012

(HealthDay) -- High-density lipoprotein cholesterol (HDL-C) is an independent risk factor for the development of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes, according to research ...

Recommended for you

Miniature pump regulates internal ocular pressure

date Jul 01, 2015

Elevated or diminished eye pressure impairs our ability to see, and in the worst cases, can even lead to blindness. Until now, there has been no effective long-term treatment. In response, Fraunhofer researchers are developing ...

Closing the Australian eye health gap may be in sight

date Jun 30, 2015

Three years after the launch of the roadmap to close the gap for vision, progress has been made but "much remains to be done", according to the authors of a Perspective published online today by the Medical Jo ...

Pioneering gene therapy takes aim at inherited blindness

date Jun 29, 2015

Canada's first human gene therapy trial for eyes—the replacement of a faulty gene with a healthy one—is now underway at the Royal Alexandra Hospital to preserve and potentially restore vision for people ...

Iris research focuses on blood vessel patterns

date Jun 29, 2015

The structure of the microvasculature or blood vessels in the iris could play an important role in people's contraction of eye maladies like glaucoma and cataract, according to a WA-led study.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.